MedPath

Electroacupuncture for Preventing Postoperative Delirium in Older Adults Undergoing Total Knee Arthroplasty

Not Applicable
Not yet recruiting
Conditions
Postoperative Delirium
Interventions
Device: Disposable acupuncture needles (0.30 × 75 mm)
Device: Placebo needles (0.30 × 25 mm)
Device: SDZ-V electroacupuncture devices
Registration Number
NCT06564506
Lead Sponsor
Fujian Provincial Hospital
Brief Summary

Electroacupuncture may improve cognitive function and altered consciousness, but its effect on postoperative delirium in older arthroplasty patients remains unexplored. This study aims to assess the efficacy of electroacupuncture in preventing postoperative delirium in older adults undergoing total knee arthroplasty.

Detailed Description

Electroacupuncture combines traditional acupuncture with electrical stimulation at specific body points. Recent clinical studies have shown promising results for acupuncture-related techniques in managing perioperative neurocognitive disorders. However, the efficacy of electroacupuncture in preventing postoperative delirium in elderly patients undergoing total knee arthroplasty remains unexplored.This randomised controlled trial aims to evaluate the efficacy of electroacupuncture in preventing postoperative delirium in elderly patients undergoing total knee arthroplasty.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
1460
Inclusion Criteria
  • Aged 65-90 years
  • American Society of Anaesthesiologists (ASA) physical status class II or III
  • Scheduled for elective unilateral total knee arthroplasty under general anesthesia
Exclusion Criteria
  • Baseline dementia or Mini-Mental State Examination (MMSE) score below 24
  • Implanted electrical devices (eg, pacemakers, brain or spinal cord neurostimulator)
  • Infection or abscess at any selected acupuncture point
  • Severe hematopoietic or hemorrhagic disease
  • Severe audio-visual impairments or inability to communicate in Mandarin
  • Alcohol or illicit drug misuse disorder
  • Current use of sedatives, antidepressants or glucocorticoids
  • Received acupuncture or electroacupuncture within one month before surgery
  • Any condition deemed unsafe or unsuitable by the research team

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active electroacupuncture groupSDZ-V electroacupuncture devicesParticipants will receive 30 minutes of active electroacupuncture before anaesthesia induction. Experienced acupuncturists will administer electroacupuncture at Shenting (GV24, 0.5 cun \[≈10 mm\] above the anterior hairline midpoint) and bilateral Benshen (GB13, 3 cun \[≈60 mm\] lateral to GV24). After skin preparation and pad placement, patients will close their eyes. Needles will be inserted 20 to 24 mm into the subgaleal layer at a flat angle, then manually manipulated to elicit de qi sensations (eg, fullness, numbness and soreness). Electrodes attached to the needle handles will deliver stimulation for 30 minutes (2 Hz/15 Hz frequency, 1 mA intensity) to cause mild skin movement without pain.
Active electroacupuncture groupDisposable acupuncture needles (0.30 × 75 mm)Participants will receive 30 minutes of active electroacupuncture before anaesthesia induction. Experienced acupuncturists will administer electroacupuncture at Shenting (GV24, 0.5 cun \[≈10 mm\] above the anterior hairline midpoint) and bilateral Benshen (GB13, 3 cun \[≈60 mm\] lateral to GV24). After skin preparation and pad placement, patients will close their eyes. Needles will be inserted 20 to 24 mm into the subgaleal layer at a flat angle, then manually manipulated to elicit de qi sensations (eg, fullness, numbness and soreness). Electrodes attached to the needle handles will deliver stimulation for 30 minutes (2 Hz/15 Hz frequency, 1 mA intensity) to cause mild skin movement without pain.
Sham electroacupuncture groupPlacebo needles (0.30 × 25 mm)Participants will receive 30 minutes of sham electroacupuncture before anaesthesia induction.The sham group will use non-acupuncture points: 20 mm above GV24 and 20 mm lateral to GB13. These points, in different dermatomes from true acupoints, minimise location-specific effects. The procedure will match the active group, excluding needle manipulation, de qi sensation and electrical output.
Sham electroacupuncture groupSDZ-V electroacupuncture devicesParticipants will receive 30 minutes of sham electroacupuncture before anaesthesia induction.The sham group will use non-acupuncture points: 20 mm above GV24 and 20 mm lateral to GB13. These points, in different dermatomes from true acupoints, minimise location-specific effects. The procedure will match the active group, excluding needle manipulation, de qi sensation and electrical output.
Primary Outcome Measures
NameTimeMethod
The incidence of postoperative delirium within the first three postoperative daysAt least two hours postsurgery and twice daily (09:00-11:00 and 18:00-20:00) for three days

The incidence of POD within the first three postoperative days will be assessed using the Confusion Assessment Method (CAM). The CAM evaluates four diagnostic features: (1) acute onset or fluctuating course, (2) inattention, (3) disorganised thinking and (4) altered consciousness. Delirium is diagnosed when features 1 and 2 are present, with either 3 or 4. Blinded investigators will assess for POD at least two hours postsurgery and twice daily (09:00-11:00 and 18:00-20:00) for three days.

Secondary Outcome Measures
NameTimeMethod
Cognitive functionAt 1, 3, 6 and 12 months postoperatively

Abbreviated Mental Test Score (AMTS) via telephone at 1, 3, 6 and 12 months postoperatively

Delirium severityAt least two hours postsurgery and twice daily (09:00-11:00 and 18:00-20:00) for three days

Delirium Rating Scale-Revised-98 (DRS-R-98); range 0-39, higher scores indicate greater severity

Postoperative painAssessed at 1, 3, 6, 12, 24, 36, 48, 60 and 72 hours postsurgery

11-point Numerical Rating Scale (0 = no pain, 10 = worst pain imaginable) at rest and movement

Postoperative morphine consumptionDuring 72 hours postsurgery

Cumulative morphine use and rescue analgesia recorded over 72 hours postsurgery

Recovery qualityAssessed daily for three days postoperatively

Chinese version of the 15-item Quality of Recovery Questionnaire (QoR-15); range 0-150, higher scores indicate better recovery

Sleep qualityAssessed preoperatively and daily for three days postoperatively

Richards-Campbell Sleep Questionnaire (RCSQ); higher mean scores indicate better sleep

Delirium subtypesAt least two hours postsurgery and twice daily (09:00-11:00 and 18:00-20:00) for three days

Richmond Agitation Sedation Scale (RASS); hypoactive (-3 to 0), hyperactive (+1 to +4) or mixed

Adverse eventsthrough study completion, an average of 7 days

Any adverse events during the study will be documented on the electronic medical records

Anxiety and depressionAssessed preoperatively and daily for three days postoperatively

Hospital Anxiety and Depression Scale (HADS); 14-item checklist (7 for anxiety, 7 for depression); each item scored 0-3; total score \>8 suggests mild disorder, \>10 moderate disorder

Trial Locations

Locations (1)

Fujian Provincial Hospital

🇨🇳

Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath